Predictive Oncology Inc. confirmed it regained compliance with Nasdaq's stockholders’ equity requirement as of November 20, 2025, following $343.5 million in private investments. This includes $50.8 million in cash and $292.7 million in crypto assets, boosting stockholders' equity over $2.5 million.